Xianglin Yuan

22PUBLICATIONS
70CO-AUTHORS
Molecular targetsCancer diagnosisRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 19, 2026
HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence.

|Jan 28, 2026
The Mechanism of Oxidative Stress in Pulmonary Fibrosis and Research Progress.

Duo Xu, Qian Wang, Meng Lyu

|Nov 19, 2025
Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis.

Chunya Li, Aifeina Aili, Qingqing Yu

|Nov 03, 2025
Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy.

Xinyi Chen, Mu Yang, Yongbiao Huang

|Apr 17, 2025
Unveiling FAM111B: A Pan-Cancer Biomarker for DNA Repair and Immune Infiltration.

Fang Wei, Wanying Li, Ting Zhou

|Jan 29, 2025
A Bifunctional Antibody Targeting PD-1 and TGF-β Signaling Has Antitumor Activity in Combination with Radiotherapy and Attenuates Radiation-Induced Lung Injury.

Sheng Wang, Duo Xu, Yuan Wang

Pageof 4

Frequent Collaborators

9 joint publications

Bo Liu

6 joint publications

Yuan Wang

4 joint publications

Yuanhui Liu

4 joint publications

Xinyi Chen